<SEC-DOCUMENT>0001104659-21-094585.txt : 20210721
<SEC-HEADER>0001104659-21-094585.hdr.sgml : 20210721
<ACCEPTANCE-DATETIME>20210721213047
ACCESSION NUMBER:		0001104659-21-094585
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210721
FILED AS OF DATE:		20210721
DATE AS OF CHANGE:		20210721

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Nagpal Amrit
		CENTRAL INDEX KEY:			0001859522

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40646
		FILM NUMBER:		211105836

	MAIL ADDRESS:	
		STREET 1:		C/O REDMILE GROUP, LLC
		STREET 2:		ONE LETTERMAN DR., BLDG. D, SUITE D3-300
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94129

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Absci Corp
		CENTRAL INDEX KEY:			0001672688
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				453931977
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		18105 SE MILL PLAIN BLVD
		CITY:			VANCOUVER
		STATE:			WA
		ZIP:			98683
		BUSINESS PHONE:		(360) 949-1041

	MAIL ADDRESS:	
		STREET 1:		18105 SE MILL PLAIN BLVD
		CITY:			VANCOUVER
		STATE:			WA
		ZIP:			98683

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AbSci Corp
		DATE OF NAME CHANGE:	20201026

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AbSci, Inc.
		DATE OF NAME CHANGE:	20201026

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AbSci, LLC
		DATE OF NAME CHANGE:	20160420
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm2122765-1_3seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2021-07-21</periodOfReport>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001672688</issuerCik>
        <issuerName>Absci Corp</issuerName>
        <issuerTradingSymbol>ABSI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001859522</rptOwnerCik>
            <rptOwnerName>Nagpal Amrit</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O REDMILE GROUP, LLC</rptOwnerStreet1>
            <rptOwnerStreet2>ONE LETTERMAN DR., BLDG. D, SUITE D3-300</rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94129</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>Amrit Nagpal is a managing director of Redmile Group, LLC (&quot;Redmile&quot;), and was elected to the Issuer's board of directors as a representative of Redmile. As a result, each of Redmile, Jeremy Green, as principal of Redmile, and Redmile Biopharma Investments II, L.P., which directly owned the Issuer's convertible preferred stock which entitled the holder to appoint one director, are a director by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.</remarks>

    <ownerSignature>
        <signatureName>/s/ Amrit Nagpal</signatureName>
        <signatureDate>2021-07-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
